Published by ICSEB at 19 March, 2012
We are pleased to invite you to attend the presentation of the director of the ICSEB “The new neuro-craneo-verebral syndrome, the most common illness. Includes Scoliosis, Syringomyelia and Arnold Chiari I Syndrome” organised by CIMA clinic in Barcelona for8th May 2012.
The program, further particulars and details will be announced shortly.
Note regarding the event:
Dr. Royo Salvador will be introducing the Neuro- Craneo- Vertebral Syndrome (SNCV), a new concept of disease described by himself since 1996 in medical publications.
The SNCV is a disease for which in the majority of cases the patient is not aware that he/she is suffering from it, given that its symptomatology is diffuse and latent, and in combination with almost imperceptible but manifest physical deterioration, it does not allow the patient nor the physician to consider it as a disease. For example, regarding one of the manfestations; the loss of strength: an adult has a grip strength of 25 to 70 kilos in the hands, and is not aware of its decrease until it reaches less than 8 kilos.
The SNCV is a consequence of the anormal traction of the “filum terminale”, (ligament that connects the spinal cord and the sacrum) and which shows primary manifestations of the entire nervous system, the brain, the spinal cord and nervous roots, of the Skull and the vertebral columna; and secondary consequences of ocular, oropharyngeal, circulatory, urinary, digestive, hormonal kind as well as of the entire organism.
The SNCV expresses itself in its maximum intensity in the form of known diseases like the Arnold Chiari I syndrome, idiopathic syringomyelia and scoliosis, basilar impression, platybasia, odontoid process, angulation of the brainstem, vertebral polydiscopathia, nocturnal enuresis, multiple cerebral infarctions, sphincter dysfunctions, hormonal dysfunctions and others.
The occurence of SNCV in the world population is of more than 10%, the proposed treatment is the “sectioning of the filum terminale” (SFT) with a minimally invasive surgery at the height of the sacrum; it is indicated for some 700 million people.
The Institut Chiari & Siringomielia & Escoliosis de Barcelona (ICSEB) complies with the established in EU regulation 2016/679 (GDPR).
The contents of this website are a non-official translation of the original content of the website in Spanish. The translation is courtesy of the Institut Chiari & Siringomielia & Escoliosis de Barcelona with the purpose of facilitating comprehension for anyone who wishes to Access the website.